|
Match
|
Document |
Document Title |
|
|
6974816 |
Combination for the treatment of endothelial damage
The invention relates to a combination of (a) an inhibitor of platelet-derived growth factor (PDGF) activity and (b) a vector for vascular endothelial growth factor (VEGF-, especially VEGF-C) gene...
|
|
|
6974593 |
Insoluble drug delivery
Particles of water insoluble biologically active compounds, particularly water-insoluble drugs, with an average size of 100 nm to about 300 nm, are prepared by dissolving the compound in a solution...
|
|
|
RE38912 |
Process for preparing powder formulations
The invention relates to a new process for producing powdered preparations for inhalation.
|
|
|
6972129 |
Method for producing cosmetics
An objective of the present invention is to provide a method for producing cosmetic products capable of improving a touch of cosmetic products containing powder and exerting the function of the...
|
|
|
6969530 |
Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
Described herein are microcapsules and emulsions prepared from low Bloom gelatin and methods of making and using thereof.
|
|
|
6969529 |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
The present invention is directed to nanoparticulate compositions comprising a poorly soluble drug and at least one copolymer of vinyl pyrrolidone and vinyl acetate as a surface stabilizer adsorbed...
|
|
|
6969531 |
Sodium hyaluronate microspheres
The present invention relates to microspheres comprising hyaluronan derivatized with a bifunctional crosslinker to form microspheres. Methods of making such microspheres, comprising mixing...
|
|
|
6969525 |
Surgically implanted time release medication for post-surgical treatment of a patient
A method of administering a medication to a post operative patient with the medication being administered at the site of a surgery performed on the patient. The medication is formed into a time...
|
|
|
6967027 |
Microfibrillated and/or microcrystalline dispersion, in particular of cellulose, in an organic solvent
The invention concerns a colloidal dispersion, in an organic solvent, of a microfibrillated and/or microcrystalline particles of a fibrillated organic substance selected among the group consisting...
|
|
|
6967017 |
Formulations of steroid solutions for inhalatory administration
The present invention relates to optimized formulations of antiinflammatory steroids for nebulisation and a process for the preparation thereof. More particularly, the invention relates to...
|
|
|
6967217 |
Process and composition for enhancing the action of vitamin a on the cellular activity of an individual, and use of vitamin c
The present invention refers to a process, a composition and the use of Vitamin C for enhancing the action of Vitamin A on the cellular activity of an individual. According to the invention, the...
|
|
|
6966990 |
Composite particles and method for preparing
A method for producing composite particles using a supercritical fluid extraction technique on an emulsion. First and second materials (for example; a polymer and a biologically active material)...
|
|
|
6964759 |
Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
Formulations for the administration through pressurized metered dose aerosol inhalers containing an anticholineric drug in solution in a hydrofluorocarbon propellant, a cosolvent and a low...
|
|
|
6962717 |
Pharmaceutical compositions
A pharmaceutical composition for slow release of active ingredient in the gastrointestinal tract, comprising a plurality of active ingredient-containing particles coated with a material insoluble...
|
|
|
6960352 |
Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent
The present invention relates generally to methods and compositions for targeting and delivering solid-phase platelet-dependent vascular occlusion agents. In particular, particles or coils or...
|
|
|
6960354 |
Membrane lipid compositions
A composition in the form of a dry powder and which comprises: a) at least one membrane lipid, and b) at least one biologically active compound comprising a xanthine and/or a carboxylic acid, and...
|
|
|
6960564 |
Echinocandin pharmaceutical formulations containing micelle-forming surfactants
Pharmaceutical formulations are described comprising an echinocandin compound or echinocandin/carbohydrate complex and a pharmaceutically acceptable micelle-forming surfactant in a non-toxic...
|
|
|
6960351 |
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
An immunoisolatory vehicle for the implantation into an individual of cells which produce a needed product or provide a needed metabolic function. The vehicle is comprised of a core region...
|
|
|
6955823 |
Process for making microcapsules involving phase inversion
A process for making microcapsules of an oil which are in dispersion in water comprises the steps of; (i) forming an initial dispersion of the oil in water in the presence of a surfactant, (ii)...
|
|
|
6955824 |
Inhalation composition containing lactose pellets
This invention relates to a pharmaceutical composition which is suitable for the administration of medicaments by inhalation. In particular, the pharmaceutical composition comprises microfine...
|
|
|
6956021 |
Stable spray-dried protein formulations
Spray-dried particles having improved protein stability are produced by spray-drying a mixture including a protein, a phospholipid and an organic-aqueous co-solvent. Spray-dried particles which...
|
|
|
6956043 |
Pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions
A pharmaceutical composition in the form of a solid dispersion comprising a macrolide, e.g. a rapamycin or an ascomycin, and a carrier medium.
|
|
|
6953593 |
Sustained-release microencapsulated delivery system
Disclosed is a process for producing sustained-release powders that is fast, efficient, and economical. The process involves melting an animal or vegetable oil with a melting point above 110...
|
|
|
6953592 |
Water soluble powders and tablets
The invention relates to water soluble or water dispersible powders, tablets, or precursors therefor based on a carbohydrate matrix with improved dissolution properties in water. These components...
|
|
|
6953588 |
Multi-vitamin and mineral supplement
This invention is directed to a multi-vitamin and mineral supplement tailored to men and post-menopausal women, pre-menopausal women, and athletes which supplies the right amount of the right...
|
|
|
6953586 |
Growth promoting pharmaceutical implant
A combination growth promoting pharmaceutical pellet system which delivers doses of both a growth stimulating pharmaceutical agent and a supplemental agent that enhances the growth produced by the...
|
|
|
6946148 |
Method for absorbing fluid
Disclosed are a fluid absorber, a method for preparing a fluid absorber, and a method for absorbing fluid from the skin. The disclosed method for preparing a fluid absorber generally comprises the...
|
|
|
6946118 |
Formulations for treating or preventing mucositis
Mucositis is treated and/or prevented by administrating to a patient a formulation comprising a tetracycline that is poorly absorbed from the gastro-intestinal tract. The tetracycline may be in the...
|
|
|
6946117 |
Stabilized preparations for use in nebulizers
Stabilized dispersions are provided for the delivery of a bioactive agent to the respiratory tract of a patient. The dispersions preferably comprise a stabilized colloidal system which may comprise...
|
|
|
6946147 |
Method of using optically-activated particles in cosmetic preparations
Optically-activated particles for use in cosmetic preparations. The optically-activated particles include a plurality of substrate particles selected from the group consisting of nylons, acrylics,...
|
|
|
6942878 |
Cosmetic composition
To provide a cosmetic composition having excellent ultraviolet protection against both UVB and UVA, causing neither unpleasant whitening to the applied skin nor skin irritation, and ensuring good...
|
|
|
6942851 |
Composition for the treatment of human hair
The invention is directed to an aqueous hair care composition comprising
a) at least one UV-absorbing substance, and b) at least one mica/titanium dioxide pigment wherein at least 90% by weight of...
|
|
|
6942877 |
Method for producing antibiotic composites
A method for producing antibiotic composites is described, which is characterized in that a salt, which can be subjected to plastic deformation and which consists of at least one cationic component...
|
|
|
6942876 |
Analgesic compositions comprising anti-epileptic compounds and methods of using same
The present invention is directed to novel combinations of anti-epileptic compounds that demonstrate pain alleviating properties, with compounds selected from the group consisting of analgesics,...
|
|
|
6939531 |
Ultrasonic imaging system utilizing a long-persistence contrast agent
A microbubble preparation formed of a plurality of microbubbles comprising a first gas and second gas surrounded by a membrane such as a surfactant, wherein the first gas and the second gas are...
|
|
|
6939534 |
Method to treat pulmonary hypoplasia in the newborn
A method of treating pulmonary hypoplasia in infants has been developed, wherein epidermal growth factor (EGF) is administered to the pulmonary system of an infant in need of treatment thereof. The...
|
|
|
6939563 |
Non-fermented osmotic laxative and method for treating and preventing colorectal cancers
Use of a non-fermented osmotic laxative as an active agent for preparation of a medicinal product for treating and/or preventing colon and/or rectum cancers. A method of treating or preventing...
|
|
|
6939568 |
Treatment of inflammatory skin conditions
The invention relates to the use of one or more antimicrobial metals, most preferably silver, preferably formed with atomic disorder, and preferably in a nanocrystalline form, for the treatment of...
|
|
|
6939530 |
Preparation of further diagnostic agents
Microspheres are prepared by a process comprising (i) spray-drying a solution or dispersion of a wall-forming material in order to obtain intermediate microspheres and (ii) reducing the...
|
|
|
6936280 |
Method for preparing a composition by extraction of mother-of-pearl, composition obtained by said method and use thereof in cosmetics and dermatology
A method for preparing a composition, comprising a) reducing mother-of-pearl into powder with grain size distribution ranging between about 1 and about 300 μm; b) placing the obtained powder in...
|
|
|
6936244 |
Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract
A composition for treatment of bacterial infections of the eye is disclosed which comprises a lytic enzyme composition specific for the infecting bacteria, and a carrier for delivering said lytic...
|
|
|
6936279 |
Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations
Zeaxanthin (ZX) or other medically or commercially important carotenoids can be prepared in microcrystalline form, in an oily carrier liquid, to increase their bioavailability following oral...
|
|
|
6936271 |
Collagenous tissue compositions
Implant compositions are disclosed consisting of a biocompatible carrier medium such as a saline or dextran solution and particles of collagenous material dispersed therein. The collagenous...
|
|
|
6936277 |
Pharmaceutical excipient having improved compressibility
A method of preparing an excipient composition includes forming an aqueous slurry containing a mixture of microcrystalline cellulose in the form of a wet cake and a surfactant, said surfactant...
|
|
|
6936278 |
Microparticles
A process for producing microparticles, in which an aqueous solution of purified amylopectin-based starch of reduced molecular weight is prepared, the solution is combined with biologically active...
|
|
|
6933310 |
Therapeutic agent for amyotrophic lateral sclerosis (ALS)
An object of the present invention is to provide a novel medicament with which motor neuron diseases can be treated. According to the present invention, there is provided a therapeutic agent for...
|
|
|
6929804 |
Anti-fungal composition
An anti-fungal product for delivering at least two different anti-fungals that is comprised of three dosage forms with different release profiles with each anti-fungal being present in at least one...
|
|
|
6929805 |
Analgesic combination
The present invention relates to medicinal preparations which can be administered orally and contain a fixed combination of at least one locally acting analgesic with a rapid onset of action and at...
|
|
|
6926908 |
Formulation for inhalation
Microparticles, obtainable by spray-drying a substantially pure solution of a therapeutic agent, consist essentially of the agent having its therapeutic activity when administered to the lung. In a...
|
|
|
6926909 |
Chrono delivery formulations and method of use thereof
A dosage formulation for once daily administration prior to sleeping is described that provides an initial delay in pharmaceutical release followed by controlled release of the pharmaceutical....
|